Dana Investment Advisors Inc. Takes $204,000 Position in Thermo Fisher Scientific Inc. (TMO)

Dana Investment Advisors Inc. purchased a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,076 shares of the medical research company’s stock, valued at approximately $204,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Tudor Investment Corp ET AL boosted its holdings in shares of Thermo Fisher Scientific by 241.8% during the first quarter. Tudor Investment Corp ET AL now owns 8,545 shares of the medical research company’s stock worth $1,313,000 after purchasing an additional 6,045 shares during the period. Flagship Harbor Advisors LLC boosted its holdings in shares of Thermo Fisher Scientific by 24.3% during the first quarter. Flagship Harbor Advisors LLC now owns 4,750 shares of the medical research company’s stock worth $725,000 after purchasing an additional 930 shares during the period. B.S. Pension Fund Trustee Ltd acting for the British Steel Pension Fund boosted its holdings in shares of Thermo Fisher Scientific by 11.2% during the first quarter. B.S. Pension Fund Trustee Ltd acting for the British Steel Pension Fund now owns 16,527 shares of the medical research company’s stock worth $2,539,000 after purchasing an additional 1,658 shares during the period. OLD Mutual Customised Solutions Proprietary Ltd. boosted its holdings in shares of Thermo Fisher Scientific by 15.5% during the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 13,172 shares of the medical research company’s stock worth $2,023,000 after purchasing an additional 1,772 shares during the period. Finally, First Financial Equity Corporation purchased a new stake in shares of Thermo Fisher Scientific during the first quarter worth about $224,000. Institutional investors and hedge funds own 86.05% of the company’s stock.

A number of analysts have recently weighed in on TMO shares. Cowen reiterated a “buy” rating and set a $200.00 target price on shares of Thermo Fisher Scientific in a report on Friday, September 1st. Morgan Stanley reissued an “overweight” rating and issued a $220.00 price target on shares of Thermo Fisher Scientific in a research note on Wednesday, September 6th. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 price target for the company in a research note on Thursday, September 7th. Barclays reissued an “overweight” rating and issued a $215.00 price target (up from $200.00) on shares of Thermo Fisher Scientific in a research note on Monday, September 25th. Finally, Goldman Sachs Group assumed coverage on shares of Thermo Fisher Scientific in a research note on Tuesday, September 26th. They issued a “buy” rating and a $225.00 price target for the company. One research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $205.21.

Thermo Fisher Scientific Inc. (NYSE TMO) opened at $191.13 on Friday. Thermo Fisher Scientific Inc. has a one year low of $139.88 and a one year high of $201.20. The firm has a market cap of $77,107.40, a P/E ratio of 21.13, a price-to-earnings-growth ratio of 1.76 and a beta of 1.06. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The business had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter last year, the firm earned $2.03 earnings per share. The business’s revenue for the quarter was up 13.9% on a year-over-year basis. equities research analysts expect that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is 10.19%.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total transaction of $9,419,500.00. Following the completion of the transaction, the chief executive officer now owns 252,577 shares of the company’s stock, valued at $47,582,981.03. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.49% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION NOTICE: This article was first posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.com-unik.info/2017/12/22/dana-investment-advisors-inc-takes-204000-position-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit